Myriam Curet Sells 2,401 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 2,401 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $205,093. The trade was a 87.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The stock was sold at an average price of $589.75, for a total value of $240,618.00.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $573.15 on Friday. The company has a market cap of $204.14 billion, a P/E ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a 50-day simple moving average of $569.87 and a two-hundred day simple moving average of $528.64.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the stock. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.